Home / Market Reports / Medical Devices & Consumables / Global Immunology-Oncology Elisa Kits Market Growth 2024-2030

Global Immunology-Oncology Elisa Kits Market Growth 2024-2030

Global Immunology-Oncology Elisa Kits Market Growth 2024-2030

Product Code:1233935

Published Date: Oct 26,2024

Pages: 88

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

Immunology-Oncology ELISA kits are laboratory tools used for the detection and quantification of specific proteins, antibodies, or biomarkers related to cancer (oncology) and immune system responses (immunology). These kits utilize the Enzyme-Linked Immunosorbent Assay (ELISA) technique, which is a highly sensitive and specific method used in immunology and cancer research to detect molecules like cytokines, tumor markers, or immune checkpoints. The kits are essential in diagnostics, research, and therapeutic development in oncology and immunology fields.

The global Immunology-Oncology Elisa Kits market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Immunology-Oncology Elisa Kits Industry Forecast” looks at past sales and reviews total world Immunology-Oncology Elisa Kits sales in 2023, providing a comprehensive analysis by region and market sector of projected Immunology-Oncology Elisa Kits sales for 2024 through 2030. With Immunology-Oncology Elisa Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunology-Oncology Elisa Kits industry.

This Insight Report provides a comprehensive analysis of the global Immunology-Oncology Elisa Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immunology-Oncology Elisa Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immunology-Oncology Elisa Kits market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunology-Oncology Elisa Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunology-Oncology Elisa Kits.

United States market for Immunology-Oncology Elisa Kits is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Immunology-Oncology Elisa Kits is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Immunology-Oncology Elisa Kits is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Immunology-Oncology Elisa Kits players cover Thermo Fisher Scientific, Bio-Techne Corporation (R&D Systems), Abcam, BioLegend (part of PerkinElmer), BD Biosciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Immunology-Oncology Elisa Kits market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Direct ELISA Kit
    Indirect ELISA Kit

Segmentation by Application:
    Cancer Diagnosis
    Pharmaceutical Industry
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Thermo Fisher Scientific
    Bio-Techne Corporation (R&D Systems)
    Abcam
    BioLegend (part of PerkinElmer)
    BD Biosciences
    MilliporeSigma (Merck KGaA)
    Enzo Life Sciences
    RayBiotech Life, Inc.
    ELISAGEN Biotech
    Creative Diagnostics

Key Questions Addressed in this Report
What is the 10-year outlook for the global Immunology-Oncology Elisa Kits market?
What factors are driving Immunology-Oncology Elisa Kits market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immunology-Oncology Elisa Kits market opportunities vary by end market size?
How does Immunology-Oncology Elisa Kits break out by Type, by Application?